{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:06:34Z","timestamp":1788901594722,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031299","name":"Calgary Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.psychres.2026.117406","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:58:46Z","timestamp":1787155126000},"page":"117406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Factors associated with antipsychotic adherence in adults with schizophrenia \u2013 A real-world evaluation"],"prefix":"10.1016","volume":"365","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9129-9236","authenticated-orcid":false,"given":"Jennifer C.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3958-7561","authenticated-orcid":false,"given":"Paul E.","family":"Ronksley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-7073","authenticated-orcid":false,"given":"Julia G.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-7388","authenticated-orcid":false,"given":"David","family":"Crockford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas P.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117406_bib0001","unstructured":"Alberta Health Services and Alberta Health, 2017. Official Standard Geographic Areas, Alberta, Canada."},{"key":"10.1016\/j.psychres.2026.117406_bib0002","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2020. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.","DOI":"10.1176\/appi.books.9780890424841"},{"issue":"9\u2013s","key":"10.1016\/j.psychres.2026.117406_bib0003","first-page":"95","article-title":"Covid-19 pandemic impact on mental health of vulnerable populations","volume":"91","author":"Amerio","year":"2020","journal-title":"Acta Biomed."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eurpsy.2011.02.005","article-title":"Interventions to improve adherence to antipsychotic medication in patients with schizophrenia\u2013a review of the past decade","volume":"27","author":"Barkhof","year":"2012","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology","volume":"34","author":"Barnes","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117406_bib0006","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fphar.2018.01540","article-title":"Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug adherence","volume":"9","author":"Burnier","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117406_bib0007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global Epidemiology and burden of Schizophrenia: findings from the Global Burden of Disease Study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.psychres.2026.117406_bib0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.9758\/cpn.2022.20.3.491","article-title":"Adherence to antipsychotic drugs by medication possession ratio for schizophrenia and similar psychotic disorders in the Republic of Korea: a retrospective cohort study","volume":"20","author":"Cho","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"7","key":"10.1016\/j.psychres.2026.117406_bib0009","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am. J. Manag. Care"},{"issue":"4","key":"10.1016\/j.psychres.2026.117406_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.apnu.2020.06.002","article-title":"A qualitative study of medication adherence amongst people with schizophrenia","volume":"34","author":"Clifford","year":"2020","journal-title":"Arch. Psychiatr. Nurs."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0011","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-03822-5","article-title":"An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders","volume":"22","author":"Crellin","year":"2022","journal-title":"BMC. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-244X-12-20","article-title":"A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia","volume":"12","author":"Dibonaventura","year":"2012","journal-title":"BMC. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117406_bib0013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11920-008-0035-0","article-title":"Insight into illness: impact on diagnosis and outcome of nonaffective psychosis","volume":"10","author":"Drake","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"issue":"9","key":"10.1016\/j.psychres.2026.117406_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057868","article-title":"Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review","volume":"12","author":"Fahrni","year":"2022","journal-title":"BMJ Open."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2012.03.018","article-title":"Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009","volume":"138","author":"Gallego","year":"2012","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117406_bib0017","first-page":"1273","article-title":"The Behavioral Model for Vulnerable populations: application to medical care use and outcomes for homeless people","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health V Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-023-00356-x","article-title":"Influencing factors of medication adherence in schizophrenic patients: a meta-analysis","volume":"9","author":"Guo","year":"2023","journal-title":"Schizophrenia"},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10597-023-01105-1","article-title":"Healthcare access for a diverse population with schizophrenia following the onset of the COVID-19 pandemic","volume":"60","author":"Horvitz-Lennon","year":"2024","journal-title":"Community Ment. Health J."},{"issue":"9","key":"10.1016\/j.psychres.2026.117406_bib0020","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.psychres.2026.117406_bib0021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/070674371506000805","article-title":"Validation of a population-based algorithm to detect chronic psychotic illness","volume":"60","author":"Kurdyak","year":"2015","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1176\/appi.ps.201600507","article-title":"Impact of physician follow-up care on psychiatric readmission rates in a population-based sample of patients with schizophrenia","volume":"69","author":"Kurdyak","year":"2018","journal-title":"Psychiatr. Serv."},{"issue":"8","key":"10.1016\/j.psychres.2026.117406_bib0023","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3111\/13696998.2013.816310","article-title":"Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia","volume":"16","author":"Lang","year":"2013","journal-title":"J. Med. Econ."},{"issue":"6","key":"10.1016\/j.psychres.2026.117406_bib0024","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/pds.3609","article-title":"Validation of a claims-based antipsychotic polypharmacy measure","volume":"23","author":"Leckman-Westin","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2026.117406_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.schres.2024.07.049","article-title":"Evaluating the impact of COVID-19 on medication adherence and health care utilization among individuals with psychotic disorders who are prescribed long-acting injectables (LAIs) or clozapine: a population-based study in Manitoba","volume":"271","author":"MacMillan-Wang","year":"2024","journal-title":"Can. Schizophr. Res."},{"issue":"9","key":"10.1016\/j.psychres.2026.117406_bib0026","first-page":"754","article-title":"Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge","volume":"21","author":"Marcus","year":"2015","journal-title":"J. Manage Care Spec. Pharm."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41537-025-00695-x","article-title":"Helping people to discontinue antipsychotics: if, when and how","volume":"11","author":"Moncrieff","year":"2025","journal-title":"Schizophrenia"},{"issue":"5","key":"10.1016\/j.psychres.2026.117406_bib0028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/pcn.12272","article-title":"Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia","volume":"69","author":"Na","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2008.11.007","article-title":"Recovery in the outpatient setting: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study","volume":"108","author":"Novick","year":"2009","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2026.117406_bib0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.24095\/hpcdp.29.4.05","article-title":"A deprivation index for health planning in Canada","volume":"29","author":"Pampalon","year":"2009","journal-title":"Chronic. Dis. Can."},{"issue":"10","key":"10.1016\/j.psychres.2026.117406_bib0031","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/ijms17101700","article-title":"Do Atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview","volume":"17","author":"Pompili","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.psychres.2026.117406_bib0032","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00127-016-1259-7","article-title":"Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study","volume":"51","author":"Rezansoff","year":"2016","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"10","key":"10.1016\/j.psychres.2026.117406_bib0033","article-title":"Validation study of health administrative data algorithms to identify individuals experiencing homelessness and estimate population prevalence of homelessness in Ontario","volume":"9","author":"Richard","year":"2019","journal-title":"Can. BMJ Open"},{"key":"10.1016\/j.psychres.2026.117406_bib0034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12875-015-0353-3","article-title":"Barriers and facilitators to primary care for people with mental health and\/or substance use issues: a qualitative study","volume":"16","author":"Ross","year":"2015","journal-title":"BMC Fam Pr."},{"issue":"1","key":"10.1016\/j.psychres.2026.117406_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Syst. Rev."},{"key":"10.1016\/j.psychres.2026.117406_bib0036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.euroneuro.2020.06.007","article-title":"Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs \u2013 A study based on blood sample analyses from 24,239 patients","volume":"37","author":"Smith","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2026.117406_bib0037","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/00048674211051618","article-title":"Antipsychotic utilisation and persistence in Australia: a nationwide 5-year study","volume":"56","author":"Taylor","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.117406_bib0038","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamapsychiatry.2018.4320","article-title":"Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia","volume":"76","author":"Tiihonen","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117406_bib0039","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/schbul\/sbj075","article-title":"Defining and assessing adherence to oral antipsychotics: a review of the literature","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.psychres.2026.117406_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264170","article-title":"An integrated continuity of care measure improves performance in models predicting medication adherence using population-based administrative data","volume":"17","author":"Yao","year":"2022","journal-title":"PLoS. One"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812600466X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812600466X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:07:48Z","timestamp":1788898068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812600466X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S016517812600466X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117406","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with antipsychotic adherence in adults with schizophrenia \u2013 A real-world evaluation","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117406"}}